- 08 October 2002
ICON Reports Strong Results with 29% increase in revenues and 27% increase in operating income in First Quarter FY 2003 (NASDAQ:ICLR)
Net revenues for the quarter were $46.9 million, representing a 29% increase over net revenues of $36.2 million for the same quarter last year.
- 07 October 2002
ICON acquires New York based specialist CRO
Based in New York, BPA specialises in clinical research services for immunosuppressant drugs, including those used to treat transplant patients, a new area of interest for ICON.
- 31 August 2002
ICON ANNOUNCES $54 MILLION IN NET NEW BUSINESS AWARDS IN FIRST QUARTER ENDED AUGUST 31, 2002 (NASDAQ:ICLR)
ICON announced that the company had been awarded $54 million of net new business in its first quarter ended August 31, 2002.
- 30 July 2002
ICON reports a 64% increase in operating income and EPS $1.16 for FY2002 (NASDAQ:ICLR)
Net revenues for the quarter were $43.0 million, representing a 36% increase over net revenues of $31.5 million for the same quarter last year.
- 12 June 2002
ICON ANNOUNCES OVER $53 MILLION IN NET NEW BUSINESS AWARDS IN FOURTH QUARTER ENDED MAY 31, 2002 (NASDAQ:ICLR)
Mr Peter Gray, the Chief Operating Officer of ICON announced that the company had been awarded over $53 million of net new business in its fourth quarter ended May 31, 2002.
- 26 March 2002
ICON reports eleventh consecutive quarter of revenue and income growth (NASDAQ:ICLR)
Net revenues for the quarter were $39.6 million, representing a 33% increase over net revenues of $29.7 million for the same quarter last year.
- 08 January 2002
ICON Reports 32% Increase in Revenues, 70% Increase in Operating Income, and 27% Increase in EPS in Second Quarter FY 2002 (NASDAQ:ICLR)
Net revenues for the quarter were $37.8 million, representing a 32% increase over net revenues of $28.6 million for the same quarter last year.
- 25 September 2001
ICON Reports Record Results with 38% increase in revenues, 76% increase in operating income and 29% increase in EPS in First Quarter FY 2002 (NASDAQ:ICLR)
Net revenues for the quarter were $36.2 million, representing a 38% increase over net revenues of $26.3 million for the same quarter last year.
- 24 July 2001
ICON Reports Another Record Quarter with 41% Increase in Revenues and 25% Increase in EPS for Fourth Quarter FY 2001 (NASDAQ:ICLR)
For the fiscal year ended May 31, 2001, net revenues were $116.2 million, an increase of 44% over the $80.8 million reported for the prior year.
- 14 June 2001
ICON ANNOUNCES OVER $45 MILLION IN NET NEW BUSINESS AWARDS IN FOURTH QUARTER ENDED MAY 31, 2001
“The continuing strength of our new order intake again emphasizes the underlying strength of pharmaceutical outsourcing”
